Discontinued — last reported Q4 '19
Humana Securities Received As Collateral increased by 129.5% to $443.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 86.9%, from $237.00M to $443.00M. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates higher levels of collateralized activity and potential liquidity buffers.
This represents the fair value of securities received from counterparties as collateral for various financial transactio...
Commonly reported by firms engaged in active securities lending and collateralized trading.
current_assets_securities_received_as_collateral| Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|
| Value | $148.00M | $127.00M | $237.00M | $128.00M | $274.00M | $193.00M | $443.00M |
| QoQ Change | — | -14.2% | +86.6% | -46.0% | +114.1% | -29.6% | +129.5% |
| YoY Change | — | — | — | — | +85.1% | +52.0% | +86.9% |